<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02999594</url>
  </required_header>
  <id_info>
    <org_study_id>mamc123</org_study_id>
    <nct_id>NCT02999594</nct_id>
  </id_info>
  <brief_title>Tramadol for Labor Analgesia: a Placebo Controlled Randomised Control Trial</brief_title>
  <official_title>Tramadol for Labor Analgesia in Low Risk Women: A Placebo Controlled Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maulana Azad Medical College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maulana Azad Medical College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tramadol for labor analgesia: a low risk placebo controlled randomised control trial
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators will administer 100mg tramadol or 2ml distilled water through intramuscular
      route in a blinded manner. Visual analogue score will be assessed in the beginning and every
      hour till four hours. patient satisfaction, safety outcomes, duration of 1st and 2nd stage of
      labor, proportion of women experiencing nausea, vomiting and increased sleepiness, postpartum
      haemorrhage,apgar score at 5 minute, need for nicu admission wiil be assessed at the end
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual analogue scale</measure>
    <time_frame>at 2nd hour of administration</time_frame>
    <description>visual analogue scale i.e scaling of severity of pain from 1 being mildest and 10 being most severe will be assessed at 2nd hour of administration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>at the end of labor( within 12 hours)</time_frame>
    <description>scale of 1-5 including highly satisfied, moderately satisfied ,it is ok ,not satisfied ,highly unsatisfied</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fetal distress</measure>
    <time_frame>during labor</time_frame>
    <description>fetal tachycardia (heart rate more than 160) or fetal bradycardia (heart rate less than 100)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of 1st and 2nd stage of labor</measure>
    <time_frame>1st and 2nd stage</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>women with side effects like postpartum haemorrhage, nausea, vomiting and increased sleepiness</measure>
    <time_frame>till the end of labor</time_frame>
    <description>increased risk of postpartum haemorrhage, nausea , vomiting and sleepiness may be associated with use of tramadol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neonatal safety in terms of apgar score and nicu admission</measure>
    <time_frame>apgar score at 0 and 5 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>need for caesarean section or instrumental delivery</measure>
    <time_frame>during labor</time_frame>
    <description>emergency caesarean section or need for forceps or vacuum application</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">86</enrollment>
  <condition>Tramadol for Labor Analgesia</condition>
  <arm_group>
    <arm_group_label>tramadol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50mg tramadol hydrochloride will be used intramuscularly as an experimental drug for evaluating its safety and efficacy as labor analgesic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>distilled water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2ml distilled water intramuscularly will be used as a placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol Hydrochloride</intervention_name>
    <description>50mg intramuscularly</description>
    <arm_group_label>tramadol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Distilled Water</intervention_name>
    <description>2ml intramuscularly</description>
    <arm_group_label>distilled water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  delivering for first time(nulliparous)

          -  well established labor ( 3 or more contractions in a span of ten minutes

          -  cervical dilation of 4 cm or more

          -  &gt;= 80% effacement of cervix

        Exclusion Criteria:

          -  any medical disorder- diabetes,hypertension

          -  obstetric high risk factors
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>dr aastha raheja</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maulana Azad Medical College</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>dr aastha raheja</last_name>
    <phone>8586032882</phone>
    <email>aastha_raheja2000@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>dr krishna agarwal</last_name>
    <phone>9871214208</phone>
    <email>drkrishna.agarwal@gmail.com</email>
  </overall_contact_backup>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2016</study_first_submitted>
  <study_first_submitted_qc>December 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2016</study_first_posted>
  <last_update_submitted>December 22, 2016</last_update_submitted>
  <last_update_submitted_qc>December 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maulana Azad Medical College</investigator_affiliation>
    <investigator_full_name>dr aastha raheja</investigator_full_name>
    <investigator_title>post graduate 1st year student obstetrics and gynecology department</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 23, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

